Skip to main content
Clinical Trials/NCT07057258
NCT07057258Enrolling By InvitationNot Applicable

Injection Versus Suture Repair of Laryngeal Clefts, A Randomized, Controlled Trial

Oregon Health and Science University4 sites in 1 country128 target enrollmentStarted: September 1, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Enrolling By Invitation
Enrollment
128
Locations
4
Primary Endpoint
Resolution of penetration/aspiration

Study Overview

Brief Summary

The purpose of the study is to learn more about a procedure that may be helpful for the participant's swallowing issues. The investigators are hoping to find out if one type of procedure is the same or better than another type of procedure at improving participant's issues with swallowing.

Participants will get one of two procedures. One is called injection laryngoplasty (IL) and injects a gel into the back wall of the participant's airway to prevent food and liquid from falling in. The other procedure is called endoscopic suture repair (ER) and uses sutures to sew together and build up the back wall of the participant's airway to prevent food and liquid from falling in. Participants will be asked to have a number of tests and procedures. These include a modified barium swallow study, in which the participant drinks and eats foods and liquids with barium in them and X-rays are used to assess how the food moves through the participant's body. This will be done before the procedure and 3 months after the procedure. The investigators will also give participants questionnaires to complete before and after the procedure.

Detailed Description

This study has 2 study groups.

  • Group 1 will get IL for this condition.
  • Group 2 will get ER for this condition

A computer will assign each participant to a group in no particular order. This is called randomization. Half of participants in this study will get IL. Half of participants will get ER. Each participant will have an equal chance of being in either group.

Neither the participants, the study doctor(s), nor the speech pathologist will know whether each participant will get the IL or ER. Only the surgeon will know which treatment the participant gets. The study is done this way because knowing which method the participant receives can change the results of the study.

If participants experience any serious side effects, the study doctor can find out which method they received so that any side effects can be treated properly.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Care Provider, Outcomes Assessor)

Eligibility Criteria

Ages
12 Months to 10 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •children aged 12 months - 10 years referred to a multi-disciplinary aerodigestive clinic with evidence of penetration or aspiration on VFSS, requiring any amount of thickening of liquids and unable to wean after 2-month trial of thickened liquids.

Exclusion Criteria

  • •Cerebral palsy
  • •Down syndrome
  • •Prematurity < 28 weeks gestational age
  • •Hypoxic brain injury
  • •Any syndrome with significant hypotonia
  • •History of nothing by mouth (NPO) for > 1 month prior to assessment
  • •>50% of nutrition by G-tube
  • •Tracheostomy
  • •History of prior IL or ER

Arms & Interventions

Endoscopic suture repair

Experimental

Children receiving endoscopic suture repair of laryngeal cleft

Intervention: Endoscopic suture repair (Procedure)

Injection laryngoplasty

Active Comparator

Children receiving injection of the interarytenoid space of laryngeal cleft

Intervention: Injection laryngoplasty (Procedure)

Outcomes

Primary Outcomes

Resolution of penetration/aspiration

Time Frame: 3 months post operative

No thickener needed on speech pathologist assessment of video fluoroscopic swallow study

Secondary Outcomes

  • change in quality of life scores(at enrollment and 3 months post intervention)
  • Compare change in recommended liquid thickness(at enrollment and 3 months post intervention)
  • change in feeding and swallowing impact survey (FSIS) scores(at enrollment and 3 months post intervention)
  • change in penetration/aspiration score(at enrollment and 3 months post intervention)
  • Change in laryngeal cleft quality of life (LC-QOL) scores(at enrollment and 3 months post intervention)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Derek Lam, MD, MPH

Professor

American Academy of Otolaryngology-Head and Neck Surgery Foundation

Study Sites (4)

Loading locations...

Similar Trials